South Korea Active Pharmaceutical Ingredients Market Size & Outlook

The active pharmaceutical ingredients market in South Korea is expected to reach a projected revenue of US$ 15,631.0 million by 2030. A compound annual growth rate of 6.8% is expected of South Korea active pharmaceutical ingredients market from 2024 to 2030.
Revenue, 2023 (US$M)
$9,837.1
Forecast, 2030 (US$M)
$15,631.0
CAGR, 2024 - 2030
6.8%
Report Coverage
South Korea

South Korea active pharmaceutical ingredients market, 2018-2030 (US$M)

South

Related Markets

South Korea active pharmaceutical ingredients market highlights

  • The South Korea active pharmaceutical ingredients market generated a revenue of USD 9,837.1 million in 2023 and is expected to reach USD 15,631.0 million by 2030.
  • The South Korea market is expected to grow at a CAGR of 6.8% from 2024 to 2030.
  • In terms of segment, synthetic was the largest revenue generating type of synthesis in 2023.
  • Biotech is the most lucrative type of synthesis segment registering the fastest growth during the forecast period.


Active pharmaceutical ingredients market data book summary

Market revenue in 2023USD 9,837.1 million
Market revenue in 2030USD 15,631.0 million
Growth rate6.8% (CAGR from 2023 to 2030)
Largest segmentSynthetic
Fastest growing segmentBiotech
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSynthetic, Biotech
Key market players worldwideDr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, AbbVie Inc, Aurobindo Pharma, Sandoz Group AG Registered Shares, Viatris Inc, Fresenius Kabi


Other key industry trends

  • In terms of revenue, South Korea accounted for 4.1% of the global active pharmaceutical ingredients market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China active pharmaceutical ingredients market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 30,904.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Active Pharmaceutical Ingredients Market Companies

Name Profile # Employees HQ Website

South Korea active pharmaceutical ingredients market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to active pharmaceutical ingredients market will help companies and investors design strategic landscapes.


Synthetic was the largest segment with a revenue share of 69.68% in 2023. Horizon Databook has segmented the South Korea active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.


The South Korean pharmaceutical industry is technologically advanced, and consumers spend significantly on healthcare. The country is also a key supplier of APIs to neighboring countries, including Japan. After India and China, the largest manufacturer of APIs is South Korea, followed by Taiwan. South Korea is the third-largest exporter of API.

In February 2021, Korean Pharmaceutical and Bio-Pharma Manufacturers Association announced that the country is aiming toward self sufficiency in the API sector and developing 200 molecules to ensure growth and supply of raw materials to over 2,000 drug manufacturers in the region.

However, key market players operating in the country are focusing on developing pharmaceuticals manufacturing industry. In November 2022, Helixmith received local license for accelerating the development of cell gene therapies in CDMOs. In July 2022, Samsung Biologics invested USD 323 million for buying land in South Korea to establish a manufacturing facility.

Reasons to subscribe to South Korea active pharmaceutical ingredients market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of South Korea active pharmaceutical ingredients market databook

  • Our clientele includes a mix of active pharmaceutical ingredients market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Korea active pharmaceutical ingredients market , including forecasts for subscribers. This country databook contains high-level insights into South Korea active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

South Korea active pharmaceutical ingredients market size, by type of synthesis, 2018-2030 (US$M)

South Korea Active Pharmaceutical Ingredients Market Outlook Share, 2023 & 2030 (US$M)

South Korea active pharmaceutical ingredients market size, by type of synthesis, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more